The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Aspirin Krka 75 mg gastro-resistant tablets

75 milligram(s) Gastro-resistant, prolonged release granules

Krka d.d., Novo mestoPA1347/070/001

Main Information

Trade NameAspirin Krka 75 mg gastro-resistant tablets
Active SubstancesAcetylsalicylic acid
Strength75 milligram(s)
Dosage FormGastro-resistant, prolonged release granules
Licence HolderKrka d.d., Novo mesto
Licence NumberPA1347/070/001

Group Information

ATC CodeB01AC Platelet aggregation inhibitors excl. heparin
B01AC06 acetylsalicylic acid

Status

Authorised/WithdrawnAuthorised
Licence Issued10/03/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back